Two draft recommendation statements find lack of evidence for dental screening, preventive interventions in children, adults
Risk up with amiodarone versus flecainide or sotalol among seniors with atrial fibrillation receiving apixaban or rivaroxaban
Increase in PE diagnosis and higher proportion of low-risk PEs, with lower proportion of ICU admissions